21 results
Keyword Enfuvirtid Remove keyword
Categories
Human Remove Human filter
-
List item
Human medicine European public assessment report (EPAR): Fuzeon
enfuvirtide, HIV Infections
Date of authorisation: 27/05/2003, Revision: 19, Authorisedcontains the active substance enfuvirtide (90 mg/ml). What is Fuzeon … active substance in Fuzeon, enfuvirtide, is a fusion inhibitor. Fuzeon … hypersensitive (allergic) to enfuvirtide or any of the other ingredients … -
List item
Human medicine European public assessment report (EPAR): Intelence
etravirine, HIV Infections
Date of authorisation: 28/08/2008, Revision: 22, Authorised -
List item
Human medicine European public assessment report (EPAR): Aptivus
tipranavir, HIV Infections
Date of authorisation: 25/10/2005, Revision: 36, Authorised -
List item
Human medicine European public assessment report (EPAR): Isentress
raltegravir, HIV Infections
Date of authorisation: 19/12/2007, Revision: 34, Authorised -
List item
Human medicine European public assessment report (EPAR): Nevirapine Teva
nevirapine, HIV Infections
Date of authorisation: 30/11/2009, Generic, Revision: 8, Authorisedadjustments. ENTRY INHIBITORS Enfuvirtide Due … -
List item
Human medicine European public assessment report (EPAR): Celsentri
maraviroc, HIV Infections
Date of authorisation: 18/09/2007, Revision: 22, Authorised -
List item
Human medicine European public assessment report (EPAR): Atripla (updated)
efavirenz / emtricitabine / tenofovir disoproxil, HIV Infections
Date of authorisation: 13/12/2007, Revision: 30, Authorisedwhereas the results with enfuvirtide suggested additivity. Tests … zalcitabine, delavirdine and enfuvirtide, as well as with adefovir … -
List item
Human medicine European public assessment report (EPAR): Dutrebis
lamivudine / raltegravir potassium, HIV Infections
Date of authorisation: 26/03/2015, Revision: 0, Withdrawn -
List item
Human medicine European public assessment report (EPAR): Rezolsta (updated)
darunavir / cobicistat, HIV Infections
Date of authorisation: 19/11/2014, Additional monitoring, Revision: 7, Authorised -
List item
Human medicine European public assessment report (EPAR): Tivicay
dolutegravir, HIV Infections
Date of authorisation: 16/01/2014, Additional monitoring, Revision: 13, Authorised -
List item
Human medicine European public assessment report (EPAR): Daklinza
daclatasvir, Hepatitis C, Chronic
Date of authorisation: 22/08/2014, Additional monitoring, Revision: 13, Authorised -
List item
Human medicine European public assessment report (EPAR): Prezista (updated)
darunavir, HIV Infections
Date of authorisation: 11/02/2007, Revision: 44, Authorised -
List item
Human medicine European public assessment report (EPAR): Stribild
elvitegravir / cobicistat / emtricitabine / tenofovir disoproxil, HIV Infections
Date of authorisation: 24/05/2013, Revision: 19, Authorisedsingle-tablet regimen T-20 enfuvirtide TAM thymidine analog-associated … -
List item
Human medicine European public assessment report (EPAR): Darunavir Krka d.d.
darunavir, HIV Infections
Date of authorisation: 18/01/2018, Generic, Revision: 1, Authorised -
List item
Human medicine European public assessment report (EPAR): Darunavir Krka
darunavir, HIV Infections
Date of authorisation: 26/01/2018, Generic, Revision: 1, Authorised -
List item
Human medicine European public assessment report (EPAR): Darunavir Mylan
darunavir, HIV Infections
Date of authorisation: 03/01/2017, Generic, Revision: 2, Authorised -
List item
Human medicine European public assessment report (EPAR): Zepatier
elbasvir / grazoprevir, Hepatitis C, Chronic
Date of authorisation: 22/07/2016, Additional monitoring, Revision: 5, Authorised -
List item
Human medicine European public assessment report (EPAR): Viramune (updated)
nevirapine, HIV Infections
Date of authorisation: 04/02/1998, Revision: 37, Authorised -
List item
Human medicine European public assessment report (EPAR): Telzir
fosamprenavir, HIV Infections
Date of authorisation: 12/07/2004, Revision: 39, Authorisedyears of age could receive enfuvirtide; NNRTIs and other PIs were … -
List item
Human medicine European public assessment report (EPAR): Vitekta
elvitegravir, HIV Infections
Date of authorisation: 13/11/2013, Additional monitoring, Revision: 4, Withdrawn -
List item
Human medicine European public assessment report (EPAR): Zerit
stavudine, HIV Infections
Date of authorisation: 08/05/1996, Revision: 30, Authorised